GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmala Biotech Holdings Inc (OTCPK:MDXXF) » Definitions » Sale Of Investment

MDXXF (Pharmala Biotech Holdings) Sale Of Investment : $0.00 Mil (TTM As of Feb. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Pharmala Biotech Holdings Sale Of Investment?

Pharmala Biotech Holdings's sale of investment for the three months ended in Feb. 2024 was $0.00 Mil. It means Pharmala Biotech Holdings gained $0.00 Mil from selling investments. Pharmala Biotech Holdings's sale of investment for the trailing twelve months (TTM) ended in Feb. 2024 was $0.00 Mil.

Compared with last quarter ($0.00 Mil in Nov. 2023 ), Pharmala Biotech Holdings gained the same money from selling investments in Feb. 2024 ($0.00 Mil).


Pharmala Biotech Holdings Sale Of Investment Historical Data

The historical data trend for Pharmala Biotech Holdings's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmala Biotech Holdings Sale Of Investment Chart

Pharmala Biotech Holdings Annual Data
Trend Aug21 Aug22 Aug23
Sale Of Investment
- - -

Pharmala Biotech Holdings Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Pharmala Biotech Holdings Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharmala Biotech Holdings Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Pharmala Biotech Holdings's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmala Biotech Holdings Business Description

Traded in Other Exchanges
Address
82 Richmond Street East, Toranto, ON, CAN, M5C 1P1
Pharmala Biotech Holdings Inc is focused on manufacturing and sales of MDMA and MDXX Active Pharmaceutical Ingredients (API) for use in clinical research. PharmAla's drug API is manufactured and encapsulated under GMP conditions. The Company generates revenue from the sale of tablets and raw MDMA and MDXX compounds/formulations.